Home › Entities › clinical_trial › Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

clinical trial
MedicalStudy clinical_trial Q66071791
Press Enter · cited answer in seconds

Summary

Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide is a clinical trial[1].

Key Facts

  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide is in the country of United States[2].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's instance of is recorded as clinical trial[3].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's start time is recorded as +2017-01-18T00:00:00Z[4].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's end time is recorded as +2020-01-31T00:00:00Z[5].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's sponsor is recorded as Loyola University Chicago[6].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's main subject is recorded as acute lymphocytic leukemia[7].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's main subject is recorded as myelodysplastic syndrome[8].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's main subject is recorded as leukemia[9].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's number of participants is recorded as {'unit': '1', 'amount': '+40'}[10].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's title is recorded as Safety, Efficacy and Feasibility of Haploidentical Stem Cell Transplantation (Haplo-SCT) Using Post-Transplant Cyclophosphamide (PTCy) as an Alternative Donor Source for Patients Who Lack a Matched Sibling/Unrelated Donor Options[11].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+16'}[12].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's ClinicalTrials.gov ID is recorded as NCT03088709[13].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+90'}[14].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's research intervention is recorded as (RS)-cyclophosphamide[15].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's clinical trial phase is recorded as phase II clinical trial[16].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's research site is recorded as Loyola University Medical Center[17].
  • Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide's study type is recorded as interventional study[18].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide. Retrieved May 3, 2026, from https://4ort.xyz/entity/haploidentical-stem-cell-transplantation-using-post-transplant-cyclophosphamide
MLA “Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/haploidentical-stem-cell-transplantation-using-post-transplant-cyclophosphamide.
BibTeX @misc{4ortxyz_haploidentical-stem-cell-transplantation-using-post-transplant-cyclophosphamide_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide}}, year = {2026}, url = {https://4ort.xyz/entity/haploidentical-stem-cell-transplantation-using-post-transplant-cyclophosphamide}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide — https://4ort.xyz/entity/haploidentical-stem-cell-transplantation-using-post-transplant-cyclophosphamide (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/haploidentical-stem-cell-transplantation-using-post-transplant-cyclophosphamide · Last refreshed: